|
ARHGEF9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.22079999734737E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58630000024473E-07 |
| Normal-vs-Stage2 |
4.682800E-03 |
| Normal-vs-Stage3 |
1.994910E-04 |
| Normal-vs-Stage4 |
1.60240000002254E-06 |
| Stage1-vs-Stage2 |
5.710200E-01 |
| Stage1-vs-Stage3 |
8.654600E-01 |
| Stage1-vs-Stage4 |
1.343440E-01 |
| Stage2-vs-Stage3 |
6.143400E-01 |
| Stage2-vs-Stage4 |
1.378030E-01 |
| Stage3-vs-Stage4 |
2.784600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73199999897733E-08 |
| Normal-vs-AfricanAmerican |
1.040510E-04 |
| Normal-vs-Asian |
1.478320E-02 |
| Caucasian-vs-AfricanAmerican |
1.092400E-01 |
| Caucasian-vs-Asian |
7.938000E-01 |
| AfricanAmerican-vs-Asian |
7.871800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.57307541729324E-12 |
| Normal-vs-Female |
2.495600E-03 |
| Male-vs-Female |
1.936870E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.65629999999895E-05 |
| Normal-vs-Extreme_Weight |
1.65299995913415E-10 |
| Normal-vs-Obese |
1.81793999999291E-05 |
| Normal-vs-Extreme_Obese |
5.638800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.521000E-01 |
| Normal_Weight-vs-Obese |
6.331800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.929600E-02 |
| Extreme_Weight-vs-Obese |
8.426100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.973500E-04 |
| Obese-vs-Extreme_Obese |
2.936000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.18839999969134E-07 |
| Normal-vs-Age(41-60Yrs) |
6.31789999999688E-05 |
| Normal-vs-Age(61-80Yrs) |
5.64150004489505E-09 |
| Normal-vs-Age(81-100Yrs) |
5.406100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.198400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.825400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.863200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.094000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.570400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.860200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.8519999935931E-09 |
| Normal-VS-Type2 PRCC |
8.44949999967426E-07 |
| Normal-VS-KIRP CIMP |
1.85151893816737E-12 |
| Normal-VS-Unclassified PRCC |
3.899900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.166000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.98889999972296E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.019580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.36169999959735E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.912210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.40259999947823E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.30209999999109E-06 |
| Normal-vs-N1 |
6.46090000389066E-08 |
| Normal-vs-N2 |
5.478100E-03 |
| N0-vs-N1 |
2.300800E-01 |
| N0-vs-N2 |
7.032800E-01 |
| N1-vs-N2 |
8.405200E-01 |
|
|
